Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival

Molecular and Cellular Biochemistry

Volumn 295, Issue 1-2, 2007, Pages 75-83

  Perdiki, Marina ^a   Korkolopoulou, Penelope ^a   Thymara, Irene ^a   Agrogiannis, George ^a   Piperi, Christina ^a   Boviatsis, Efstathios ^a   Kotsiakis, Xenophon ^a   Angelidakis, Dimitrios ^a   Diamantopoulou, Kalliopi ^b   Thomas Tsagli, Euphemia ^b   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Asklepeion Hospital   (Greece)

Author keywords

Astrocytoma; COX 2; HIF 1 ; Hypoxia; VEGF

Indexed keywords

ANGIOGENIC FACTOR; CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ANAPLASTIC CARCINOMA; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; ASTROCYTOMA; CYCLOOXYGENASE 2; FEMALE; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KI-67 ANTIGEN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846496221     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9275-7     Document Type: Article

References (47)

1. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE (1998) Cyclooxygenase in biology, disease Faseb J 12(12):1063-1073
2. Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (part I) J Natl Cancer Inst 90(20):1529-1536
3. DuBois RN, Awad J, Morrow J, Roberts LJ 2nd, Bishop PR (1994) Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester J Clin Invest 93(2):493-498
4. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J Biol Chem 266(20):12866-12872
5. Pairet M, Engelhardt G (1996) Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: Possible physiological and therapeutic implications Fundam Clin Pharmacol 10(1):1-17
6. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression Proc Natl Acad Sci USA 99(21):13926-13931
7. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF (2001) Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations Cancer Res 61(11):4375-4381
8. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328(18):1313-1316
9. Thun MJ, Namboodiri MM, Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325(23):1593-1596
10. Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA (2000) The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis Cancer Res 60(18):5040-5044
11. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87(5):803-809
12. Paoletti P, Chiabrando C, Gaetani P, Castelli MG, Butti G, Martelli L, Rolli M (1989) Prostaglandins in human brain tumors J Neurosurg Sci 33(1):65-69
13. Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ (1997) Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction Cancer Res 57(12):2452-2459
14. Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V, Reddy BS (1995) Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent Cancer Res 55(7):1464-1472
15. Reddy BS, Rao CV, Seibert K (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis Cancer Res 56(20):4566-4569
16. Deininger MH, Weller M, Streffer J, Mittelbronn M, Meyermann R (1999) Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo Acta Neuropathol (Berl) 98(3):240-244
17. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM (2000) Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398 Cancer Res 60(17):4926-4931
18. Matsuo M, Yonemitsu N, Zaitsu M, Ishii K, Hamasaki Y, Fukuyama K, Tabuchi K, Miyazaki S (2001) Expression of prostaglandin H synthase-2 in human brain tumors Acta Neuropathol (Berl) 102(2):181-187
19. Castilla EA, Prayson RA, Kanner AA, Rybicki LA, Tubbs RR, Vogelbaum MA, Barnett GH (2003) Cyclooxygenase-2 in oligodendroglial neoplasms Cancer 98 (7):1465-1472
20. Castelli MG, Chiabrando C, Fanelli R, Martelli L, Butti G, Gaetani P, Paoletti P (1989) Prostaglandin and thromboxane synthesis by human intracranial tumors Cancer Res 49(6):1505-1508
21. Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ (2000) Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor Clin Cancer Res 6(6):2513-2520
22. Folkman J (1995) Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis N Engl J Med 333(26):1757-1763
23. Fosslien E (2001) Review: Molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis Ann Clin Lab Sci 31(4):325-348
24. 2 homeostasis by hypoxia-inducible factor 1 Annu Rev Cell Dev Biol 15:551-578
25. Wenger RH, Gassmann M (1997) Oxygen(es) and the hypoxia-inducible factor-1 Biol Chem 378(7):609-616
26. Korkolopoulou P, Patsouris E, Konstantinidou AE, Pavlopoulos PM, Kavantzas N, Boviatsis E, Thymara I, Perdiki M, Thomas-Tsagli E, Angelidakis D, Rologis D, Sakkas D (2004) Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis Neuropathol Appl Neurobiol 30(3):267-278
27. Cavenee WKFF, Nagane M, Huang H-JS, Newcomb EW, Bigner D, Weller M, Berens ME, Plate KH, Israel MA, Noble MD, Kleihues P (2000) Diffusely infiltrating astrocytomas. In: P Kleihues, Cavenee WK (eds) International Agency for Research on Cancer. Pathology and Genetics of Tumours of the Nervous System. IARC Press, Lyon, pp 10-21
28. Korkolopoulou P, Patsouris E, Kavantzas N, Konstantinidou AE, Christodoulou P, Thomas-Tsagli E, Pananikolaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, Rologis D, Davaris P (2002) Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms Neuropathol Appl Neurobiol 28(1):57-66
29. Shrieve DC, Alexander E 3rd, Black PM, Wen PY, Fine HA, Kooy HM, Loeffler JS (1999) Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome J Neurosurg 90(1):72-77
30. Inoue H, Kosaka T, Miyata A, Hara S, Yokoyama C, Nanayama T, Tanabe T (1995) Structure and expression of the human prostaglandin endoperoxide synthase 2 gene Adv Prostaglandin Thromboxane Leukot Res 23:109-111
31. Sairanen T, Ristimaki A, Karjalainen-Lindsberg ML, Paetau A, Kaste M, Lindsberg PJ (1998) Cyclooxygenase-2 is induced globally in infarcted human brain Ann Neurol 43(6):738-747
32. Elder DJ, Halton DE, Hague A, Paraskeva C (1997) Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression Clin Cancer Res 3(10):1679-1683
33. Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H, Kamada T (1996) Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines Prostaglandins Leukot Essent Fatty Acids 55(3):179-183
34. Dassesse T, de Leval X, de Leval L, Pirotte B, Castronovo V, Waltregny D: Activation of the thromboxane A(2) pathway in human prostate cancer correlates with tumor Gleason score, pathologic stage. Eur Urol, 2006, Feb 23 (Epub ahead of print)
35. Komhoff M, Guan Y, Shappell HW, Davis L, Jack G, Shyr Y, Koch MO, Shappell SB, Breyer MD (2000) Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas Am J Pathol 157(1):29-35
36. Wadhwa P, Goswami AK, Joshi K, Sharma SK (2005) Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder Int Urol Nephrol 37(1):47-53
37. Juuti A, Louhimo J, Nordling S, Ristimaki A, Haglund C (2006) Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer J Clin Pathol 59(4):382-386
38. Nakopoulou L, Mylona E, Papadaki I, Kapranou A, Giannopoulou I, Markaki S, Keramopoulos A (2005) Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma Pathobiology 72(5):241-249
39. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B (1992) Clonal expansion of p53 mutant cells is associated with brain tumour progression Nature 355(6363):846-847
40. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ (1999) Inhibition of cyclooxygenase-2 gene expression by p53 J Biol Chem 274(16):10911-10915
41. Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA (1999) Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs Cancer Res 59(17):4356-4362
42. Masunaga R, Kohno H, Dhar DK, Ohno S, Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H, Nagasue N (2000) Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients Clin Cancer Res 6(10):4064-4068
43. Fosslien E (2000) Escape from immunological surveillance in blastocyst implantation and cancer Ann Clin Lab Sci 30:111-112
44. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN (2000) Host cyclooxygenase-2 modulates carcinoma growth J Clin Invest 105(11):1589-1594
45. Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms Int J Cancer 59(4):520-529
46. Leon SP, Folkerth RD, Black PM (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors Cancer 77(2):362-372
47. Buccoliero AM, Caldarella A, Arganini L, Mennonna P, Gallina P, Taddei A, Taddei GL (2004) Cyclooxygenase-2 in oligodendroglioma: Possible prognostic significance Neuropathology 24(3):201-207